Tanahashi model domain | IVON-IS outcome measure | Operational definition | ||
---|---|---|---|---|
Preventive/promotive care | Existing management procedures | FCM treatment | ||
Availability coverage | Trained human resource availability | The proportion of target health workers at each site who have been trained on the screening and other preventive care protocols for antepartum and postpartum anaemia (including health education and nutrition) | The proportion of target health workers at each site who have been trained on the screening and management protocols for antepartum and postpartum anaemia (including preventive, promotive, diagnostic, and treatment) | The proportion of target health workers at each site who have been trained in administering FCM. These health workers are from health facilities that have not yet been exposed to training or implementation of IV FCM. |
Accessibility coverage | Service accessibility | The proportion of women attending antenatal and postnatal clinics who were offered screening and promotive care | The proportion of women diagnosed with anaemia who were prescribed treatment for anaemia | The proportion of women eligible to receive the IV FCM for pregnancy and/or postpartum anaemia who were offered the infusion. |
Acceptability coverage | Acceptability | The proportion of eligible women who were screened and who utilised other promotive care provided | The proportion of eligible women who used the prescribed treatment option | The proportion of women eligible to receive the IV FCM for pregnancy and/or postpartum anaemia who consented to receive the infusion |
Contact coverage | Service utilisation | Same with acceptability | Same with acceptability | The proportion of women eligible to receive the IV FCM for pregnancy and/or postpartum anaemia who were administered the infusion irrespective of the protocols. |
Effective/quality coveragea | Implementation fidelity | The proportion of eligible women screened for anaemia who adhered to the post-screening plan (e.g. referral for treatment of diagnosed anaemia or prescribed nutritional supplements) | The proportion of women with anaemia who used the treatment option according to the prescribed plan (e.g. dose/duration) | The proportion of women eligible to receive the IV FCM for pregnancy and/or postpartum anaemia who were administered the infusion according to the protocols. |